Medtronic's pivotal US CoreValve study proceeding as planned
This article was originally published in Clinica
Executive Summary
The trial of Medtronic's transcatheter aortic heart valve, CoreValve, is advancing, with the first patients having now received the device. The company hopes the study will secure US approval for the device.